Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 11/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.61 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.61 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29687817 | 1.00 | LTA4H (0.70) | LTA4HCYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL10908490 | 1.00 | LTA4H (0.70) | LTA4HCYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL30074475 | 0.86 | CYP1A2 (0.62) | LTA4HCYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL19859923 | 0.86 | SLC1A3 (0.80) | LTA4HCYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2522620 | 0.84 | LTA4H (0.91) | LTA4HSLC1A3SLC1A2SLC1A1MAPT | |
| SCHEMBL176813 | 0.84 | LTA4H (0.91) | LTA4HSLC1A3SLC1A2SLC1A1MAPT | |
| SCHEMBL20238889 | 0.82 | LTA4H (1.00) | LTA4HSLC1A3SLC1A2SLC1A1MAPT | |
| SCHEMBL20238887 | 0.82 | LTA4H (1.00) | LTA4HSLC1A3SLC1A2SLC1A1MAPT | |
| SCHEMBL29395053 | 0.81 | LTA4H (0.62) | LTA4HCYP1A2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL3096584 | 0.81 | CYP1A2 (0.73) | CYP1A2MEN1KMT2AMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | OHIO STATE INNOVATION FOUNDATION | 2024-03-28 | — | — | US | claimed |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| US-11814341-B2 | Non-peptidic cell-penetrating motifs | OHIO STATE INNOVATION FOUNDATION (US) | 2023-11-14 | — | — | US | claimed |
| US-20230212235-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-06 | — | — | US | claimed |
| WO-2021138397-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | OHIO STATE INNOVATION FOUNDATION (US) | 2021-07-08 | — | — | WO | claimed |
| US-20260098262-A9 | COMPOUNDS AND METHODS FOR SKIPPING EXON 44 IN DUCHENNE MUSCULAR DYSTROPHY | ENTRADA THERAPEUTICS INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260070948-A1 | CYCLIC CELL-PENETRATING PEPTIDES WITH CARGO | OHIO STATE INNOVATION FOUNDATION (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260070947-A1 | CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS | OHIO STATE INNOVATION FOUNDATION (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4706689-A2 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | Entrada Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260028630-A1 | HYBRID OLIGONUCLEOTIDES | ENTRADA THERAPEUTICS INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260008813-A1 | CELL-PENETRATING PEPTIDE COMPOUNDS | OHIO STATE INNOVATION FOUNDATION (US) | 2026-01-08 | — | — | US | disclosed |
| US-20260008812-A1 | CELL-PENETRATING PEPTIDE COMPOUNDS | OHIO STATE INNOVATION FOUNDATION (US) | 2026-01-08 | — | — | US | disclosed |
| WO-2019148195-A2 | CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-01 | — | — | WO | disclosed |
| WO-2019148194-A2 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-01 | — | — | WO | disclosed |
| WO-2019148194-A2 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-01 | — | — | WO | disclosed |
| WO-2019148195-A2 | CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-01 | — | — | WO | disclosed |
| WO-2019070962-A1 | BICYCLIC PEPTIDYL INHIBITORS | OHIO STATE INNOVATION FOUNDATION (US) | 2019-04-11 | — | — | WO | disclosed |
| WO-2019070962-A1 | BICYCLIC PEPTIDYL INHIBITORS | OHIO STATE INNOVATION FOUNDATION (US) | 2019-04-11 | — | — | WO | disclosed |
| WO-2018098231-A1 | CELL-PENETRATING PEPTIDE SEQUENCES | OHIO STATE INNOVATION FOUNDATION (US) | 2018-05-31 | — | — | WO | disclosed |
| WO-2018098231-A1 | CELL-PENETRATING PEPTIDE SEQUENCES | OHIO STATE INNOVATION FOUNDATION (US) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028630-A1 | HYBRID OLIGONUCLEOTIDES | RNGTT, BCDIN3D, RNMT | LTA4H 4328/4885CYP1A2 4866/4885SLC1A3 935/4885 |
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | TIMM50, TIMM10, PITRM1 | LTA4H 3859/4885CYP1A2 4766/4885SLC1A3 757/4885 |
| US-20260008812-A1 | CELL-PENETRATING PEPTIDE COMPOUNDS | SLC38A7, SLC7A1, SLC6A7 | LTA4H 3540/4885CYP1A2 4033/4885SLC1A3 20/4885 |
| US-20230212235-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | LNPEP, SPPL2B, CNBP | LTA4H 4316/4885CYP1A2 4885/4885SLC1A3 508/4885 |
| US-20260098262-A9 | COMPOUNDS AND METHODS FOR SKIPPING EXON 44 IN DUCHENNE MUSCULAR DYSTROPHY | UTRN, SMN1; SMN2, UPF1 | LTA4H 3638/4885CYP1A2 4811/4885SLC1A3 30/4885 |
| US-20260070947-A1 | CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS | SLC7A1, SLC38A7, SLC6A19 | LTA4H 4237/4885CYP1A2 4771/4885SLC1A3 22/4885 |
| US-11814341-B2 | Non-peptidic cell-penetrating motifs | TIMM50, TIMM10, PITRM1 | LTA4H 3859/4885CYP1A2 4766/4885SLC1A3 757/4885 |
| US-20260070948-A1 | CYCLIC CELL-PENETRATING PEPTIDES WITH CARGO | SLC7A1, SLC38A7, SLC6A19 | LTA4H 3988/4885CYP1A2 4695/4885SLC1A3 11/4885 |
| US-20260008813-A1 | CELL-PENETRATING PEPTIDE COMPOUNDS | SLC7A1, SLC38A7, SLC6A19 | LTA4H 3896/4885CYP1A2 4565/4885SLC1A3 11/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | LTA4H 4052/4885CYP1A2 4838/4885SLC1A3 1993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.